---
provider: openai
model: o3-deep-research-2025-06-26
cached: false
start_time: '2025-12-27T20:57:00.654289'
end_time: '2025-12-27T21:04:00.494692'
duration_seconds: 419.84
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: RAB7A
  gene_symbol: RAB7A
  uniprot_accession: P51149
  protein_description: 'RecName: Full=Ras-related protein Rab-7a {ECO:0000305}; EC=3.6.5.2
    {ECO:0000269|PubMed:20028791};'
  gene_info: Name=RAB7A {ECO:0000312|HGNC:HGNC:9788}; Synonyms=RAB7;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the small GTPase superfamily. Rab family.
  protein_domains: P-loop_NTPase. (IPR027417); Small_GTP-bd. (IPR005225); Small_GTPase.
    (IPR001806); Ras (PF00071)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    top_p: 1.0
citation_count: 119
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P51149
- **Protein Description:** RecName: Full=Ras-related protein Rab-7a {ECO:0000305}; EC=3.6.5.2 {ECO:0000269|PubMed:20028791};
- **Gene Information:** Name=RAB7A {ECO:0000312|HGNC:HGNC:9788}; Synonyms=RAB7;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Ras (PF00071)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB7A" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB7A' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB7A** (gene ID: RAB7A, UniProt: P51149) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# Introduction  
RAB7A (Ras-related protein Rab-7a) is a human gene encoding a small GTP-binding protein of the Rab family, part of the Ras superfamily of regulatory GTPases ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=RAB%20family%20members%20are%20small%2C,provided%20by%20RefSeq%2C%20Jul%202008)). The protein, often simply called Rab7, acts as a molecular switch cycling between an active GTP-bound state and an inactive GDP-bound state. Rab7A is ubiquitously expressed in human tissues (for example, its mRNA is abundantly present in brain and adipose with RPKM ~100) ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=Expression%20Ubiquitous%20expression%20in%20brain,25%20other%20tissues%20See%20more)), consistent with a fundamental housekeeping role in cells. It localizes primarily to the cytosolic face of late endosomes and lysosomes, where it directs vesicular traffic from early endosomes to late endosomal compartments ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). In effect, Rab7A is often described as a *master regulator* of endosome maturation and transport to lysosomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative)). This central role underlies its involvement in critical processes such as degradation of internalized proteins, recycling of membrane components, and autophagy. Below, we discuss the structure and mechanism of Rab7A, its functions in cellular pathways, subcellular localization and regulation, and its significance in health and disease, incorporating recent research findings (primarily from 2023–2024) and expert analyses.

## Rab7A as a Small GTPase: Structure and Molecular Mechanism  
Rab7A belongs to the small GTPase family, proteins that function as molecular switches to regulate diverse cellular processes. Like other Rab GTPases, Rab7A consists of about 200 amino acids forming a conserved GTP-binding domain (with characteristic P-loop, switch I and II motifs) that binds and hydrolyzes GTP ([go.drugbank.com](https://go.drugbank.com/polypeptides/P51149#:~:text=Ras,transport%20%2F%20epidermal%20growth%20factor)) ([go.drugbank.com](https://go.drugbank.com/polypeptides/P51149#:~:text=,transport%20%2F%20epidermal%20growth%20factor)). The protein is anchored to endosomal and lysosomal membranes via post-translational prenylation at its C-terminus, allowing it to cycle between membrane-bound and cytosolic states depending on its nucleotide-bound form ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and)). In the GTP-bound (active) state, Rab7A undergoes a conformational change in its switch regions enabling it to recruit a variety of effector proteins. Upon GTP hydrolysis (GDP-bound state), it releases from membranes and inactivates, ceasing effector interactions ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=the%20sites%20of%20mitochondrial%20fission,review%20will%20discuss%20the%20GEF)). This GTP/GDP cycle is tightly regulated by accessory proteins: guanine nucleotide exchange factors (GEFs) catalyze the exchange of GDP for GTP to activate Rab7A, whereas GTPase-activating proteins (GAPs) accelerate GTP hydrolysis to inactivate Rab7A ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=retromer%20complexes%20and%20the%20dynactin,review%20will%20discuss%20the%20GEF)). For example, the heterodimeric complex Mon1–Ccz1 serves as a GEF specific for Rab7 on endosomal membranes, ensuring Rab7A is activated at the correct time and place during endosome maturation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of)). Conversely, several TBC-domain containing proteins function as Rab7A GAPs to terminate its activity, and their specificity is generally determined empirically given the large number of Rabs and GAPs in cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by)). Through this regulated switch mechanism, Rab7A acts as an on-demand recruiter of downstream effectors that execute membrane trafficking events.

When Rab7A is in its GTP-bound active form, it interacts with multiple effector proteins that mediate subsequent steps in vesicle transport and fusion. Notable effectors of Rab7A include the HOPS complex (a multi-subunit tethering complex required for late endosome–lysosome fusion), the retromer complex (which recycles specific cargos from endosomes to the Golgi), and Rab-interacting lysosomal protein (RILP) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP)). RILP is particularly important as it links Rab7A-positive vesicles to the cytoskeletal motor machinery: RILP directly recruits the dynein–dynactin motor complex by binding to dynactin’s p150^Glued subunit ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001)). Through RILP, active Rab7A “hitches” late endosomes and lysosomes onto dynein motors, driving their transport along microtubules toward the perinuclear region ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma)). This activity is critical for moving vesicles centripetally and positioning lysosomes within the cell. Additionally, other effectors like FYCO1 bind Rab7A to mediate transport in the opposite direction (toward microtubule plus ends), balancing organelle positioning between the cell center and periphery ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001)). Thus, by cycling between states and engaging different effectors, Rab7A orchestrates both the movement of endosomal vesicles and their readiness for fusion or cargo sorting.

## Role in Endosomal Trafficking and Receptor Degradation  
**Endosome Maturation:** Rab7A’s most well-established function is guiding the maturation of endosomes and their progression into degradative compartments. It is predominantly associated with late endosomes and lysosomes, and is essential for the transition from early endosomes (marked by Rab5) to late endosomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=compartments%2C%20which%20are%20linked%20maturationally,E18%20rat%20hippocampal%20neurons%20of)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). During this progression, Rab7A is recruited to maturing endosomal membranes (as Rab5 dissociates) in a process often termed “Rab conversion,” which marks the commitment of an endosome to the late endocytic pathway. Rab7A then facilitates the formation of multivesicular bodies and the movement of these late endosomes along microtubules via dynein, bringing them into proximity with perinuclear lysosomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma)). A 2022 cell-biological study highlighted that Rab7 is required not only for the motility of endosomes but also for their maturation into fusion-competent organelles: experimentally disrupting dynein–dynactin or Rab7 function caused late endosomes to accumulate with excess Rab7 and delayed their fusion with lysosomes, thereby blocking cargo degradation ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=flux%20of%20late%20endosomes,dependent%20dynein%2Fdynactin%20recruitment)). In summary, Rab7A acts as a switch that triggers the late-stage maturation of endosomes and their convergence with lysosomes.

**Cargo Transport and Degradation:** Once active on a late endosome, Rab7A directly contributes to the degradation of endocytic cargo by enabling fusion with lysosomes. It plays a fundamental role in the trafficking and down-regulation of signaling receptors and other proteins internalized at the cell surface. For instance, the epidermal growth factor receptor (EGFR) must be transported to lysosomes for signal termination and degradation, a process that requires functional Rab7A ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). If Rab7A activity is impaired (for example, by dominant-negative mutants or gene knockdown), cargo such as EGFR or low-density lipoprotein (LDL) receptors accumulate in swollen late endosomal vacuoles and fail to be degraded, underscoring Rab7A’s necessity for the endosome-lysosome fusion step ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative)). Rab7A also participates in the turnover of adhesion molecules and other plasma membrane proteins by routing them into lysosomal pathways ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). In addition to promoting degradation, Rab7A coordinates with recycling pathways: through effectors like the retromer complex, Rab7A helps sort certain receptors (for example, the cation-independent mannose-6-phosphate receptor or trophic factor receptors) away from degradation and toward recycling routes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=leading%20to%20an%20ulcero,We%20further%20discuss%20the%20current)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). In neurons, this sorting function is particularly important for long-range signaling endosomes – for example, Rab7A helps regulate the retrograde transport of nerve growth factor (NGF)–TrkA receptor complexes from the axon terminal to the cell soma, ensuring proper signal propagation for neuron survival ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body)). Taken together, Rab7A is central to determining the fate of endocytosed proteins, balancing whether they will be recycled or sent for destruction, and thereby maintaining cellular proteostasis ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=Intracellular%20endosomal%20trafficking%20controls%20the,such%20as%20coordination%20of%20recycling)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic)).

**Lysosome Biogenesis and Positioning:** Beyond cargo sorting, active Rab7A influences the biology of lysosomes themselves. It has been shown to contribute to lysosome biogenesis and the maintenance of lysosomal morphology ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). Rab7A-positive late endosomes often fuse with pre-existing lysosomes, delivering membrane and content that can enlarge or replenish lysosomal compartments. In addition, by controlling motor attachment via RILP (dynein-based inward transport) and other effectors, Rab7A impacts lysosome positioning within the cell ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). Perinuclear positioning of lysosomes, driven by Rab7A–RILP–dynein, can affect cellular processes like nutrient signaling and degradative capacity, while release of Rab7A activity (or engagement of opposite motors) allows lysosomes to scatter toward the cell periphery when needed. Thus, Rab7A not only guides vesicles to lysosomes but also helps organize the lysosomal compartment’s distribution and dynamics in the cell.

## Role in Autophagy and Organelle Dynamics  
Beyond classical endocytosis, Rab7A is a crucial player in macroautophagy – the process by which cells degrade cytosolic components and organelles via autophagosomes and lysosomes. Autophagosomes are double-membraned vesicles that form around cargo destined for degradation, and they must fuse with lysosomes to become autolysosomes where hydrolysis occurs. Rab7A is required for this autophagosome–lysosome fusion step, acting on the autophagosome membrane similarly to how it operates on late endosomes ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=Drosophila%20melanogaster,Nerve)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo)). During autophagy, Rab7A is recruited to autophagosome membranes after their formation, and it works in concert with tethering complexes like HOPS and membrane fusion SNARE proteins to promote the autophagosome’s merger with a Rab7-positive lysosome ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=enzymatic%20degradation%20happens,lifespan%2C%20climbing%20ability%2C%20and%20autophagy)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo)). Experimental evidence shows that loss of Rab7A function can cause an accumulation of incomplete autophagic vacuoles – autophagosomes that have not fused with lysosomes – leading to impaired degradation of autophagy substrates. For example, a study on neuronal cells demonstrated that constitutive activation of Rab7 (simulating a state where Rab7 cannot turn off) actually **inhibited** autophagic flux, likely by tethering lysosomes in an arrested state ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases)). This finding highlights that Rab7A’s GTP/GDP cycling is essential: the protein must be turned on to initiate fusion, but later turned off to allow the final maturation and content degradation to proceed ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma)). In summary, Rab7A is indispensable for the late stage of autophagy, ensuring autophagosomes fuse with lysosomes so that cellular waste and damaged organelles are broken down.

Rab7A’s role in autophagy also extends to organelle quality control, notably in **mitophagy** – the selective autophagic removal of mitochondria. Rab7A has been implicated in the formation of mitophagosomes and their fusion with lysosomes, facilitating the clearance of dysfunctional mitochondria ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36449254/#:~:text=Lysosome%20Fusion%20in%20N2a%20Cells,we%20show%20that%20RAB7A%2C%20a)). Additionally, Rab7A helps regulate contacts between lysosomes and mitochondria. These inter-organelle contact sites have emerged as important hubs for exchanging signals and lipids; Rab7A localizes to mitochondria–lysosome contact points and evidence suggests it can trigger contact formation or dissociation via its GTPase activity ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in)). A recent study (2023) demonstrated that Rab7A-mediated GTP hydrolysis is required to *untether* mitochondria–lysosome contacts, essentially acting as a timer for how long the two organelles stay docked ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in)). In healthy cells, transient contacts allow lysosomes to help position and divide mitochondria, a process necessary for proper mitochondrial fission and distribution ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,Accessory)). Rab7A’s involvement in this process was dramatically illustrated by disease-associated mutants (see below): a Charcot–Marie–Tooth neuropathy-causing Rab7A mutant (V162M) was shown to have reduced GTPase activity, causing prolonged and excessive tethering of mitochondria to lysosomes in neurons ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in)). This aberrant persistence of contacts led to downstream defects in mitochondrial dynamics and function. Thus, Rab7A is emerging not only as a facilitator of vesicle fusion but also as a regulator of organelle communication and dynamics within cells. Its activity finely balances events like autophagosome clearance and mitochondrial fission, underscoring how Rab7A links the endolysosomal system with other cellular homeostasis mechanisms.

## Subcellular Localization and Regulation  
Rab7A is predominantly localized to late endosomes, multivesicular bodies, and lysosomes on the cytoplasmic side of their limiting membranes ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). It achieves membrane attachment through two C-terminal geranylgeranyl lipid modifications, which anchor the protein into the lipid bilayer when it is in its active conformation. Localized activation of Rab7A is crucial; the cell exerts tight spatial control over where Rab7A switches “on.” As mentioned, the Mon1–Ccz1 complex activates Rab7A specifically on late endosomal/autophagosomal membranes, and not on earlier endosomes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of)). This ensures Rab7A is mainly present on more mature vesicles. Conversely, when a Rab7A-bearing vesicle fuses with a lysosome or when its task is completed, a GAP triggers GTP hydrolysis, causing Rab7A to dissociate into the cytosol. GDP-bound Rab7A is kept soluble in the cytoplasm by forming a complex with GDP-dissociation inhibitor (GDI), which escorts Rab proteins in their inactive state. GDI recycling of Rab7A prevents premature re-association with membranes until a new GEF (like Mon1–Ccz1) inserts Rab7A onto a target organelle ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by)). Through this cycle, Rab7A can be repeatedly used and targeted to the correct membranes in the cell.

Multiple layers of regulation modulate Rab7A activity. In addition to GEFs/GAPs, there are upstream signaling pathways and protein modifications that influence Rab7A function. For instance, some protein kinases can phosphorylate Rab7 or its effectors to alter their activity. A recent study identified a “Rab7A phosphoswitch” mechanism involving a kinase (LRRK1) that phosphorylates the Rab7A-specific GAP TBC1D2/Armus, thereby modulating Rab7A activity during growth factor signaling ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Armus%20also%20acts%20in%20autophagy,When%20Armus%20is)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab5%20on%20late%20endosomes%2C%20i,functions%20in%20their%20respective%20organisms)). Moreover, lipid environment plays a role: late endosomal membranes enriched in phosphatidylinositol-3-phosphate (PI3P) help recruit Mon1–Ccz1, linking Rab7A activation to the presence of PI3P on mature endosomes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy)). This coordination means that only endosomes that have acquired the correct lipid and protein markers (signifying maturity) will activate Rab7A. There is also interplay with other Rab proteins – for example, the prior Rab5 on early endosomes must be inactivated/removed (a process aided by Rab7A’s GEF Mon1-Ccz1 and a Rab5 GAP) to allow Rab7A to take over; this sequential handoff is a hallmark of endosomal maturation ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=is%20particularly%20important%20in%20the,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial)). In summary, Rab7A’s localization to late endosomal and lysosomal membranes, and its timely activation there, are achieved by dedicated regulatory factors that integrate signals about organelle identity and cellular needs.

## Biological Pathways and Interactions  
Rab7A’s activity touches several biological pathways and cellular functions. In the **endocytic pathway**, as detailed, it governs the fate of internalized material by facilitating degradation versus recycling decisions. Through this role, Rab7A indirectly influences signaling pathways: for example, dampening of growth factor signaling occurs when Rab7A directs activated receptors to lysosomes for down-regulation ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). In immune cells, Rab7A is required for phagosome maturation – the process by which phagocytosed particles (like bacteria) are delivered to lysosomes (forming phagolysosomes) for destruction ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)). Rab7A also interfaces with the **retromer pathway** (retrograde transport to the Golgi). By interacting with retromer components (such as VPS35), Rab7A helps retrieve certain receptors and hydrolases from late endosomes back to the trans-Golgi network ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=switches%20direct%20activity%20at%20endosomal,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial)). This step is crucial for recycling enzymes (like lysosomal hydrolases tagged with mannose-6-phosphate) and sustaining lysosome function. 

Intriguingly, Rab7A has been implicated in cell signaling beyond its trafficking duties. A recent oncology study found that Rab7A in B-lymphocytes is involved in assembling intracellular signaling complexes that activate NF-κB, a key transcription factor in immune responses ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells)). Upon B-cell stimulation, Rab7-positive endosomal membranes can serve as platforms (often called “signalosomes”) where signaling molecules gather, and Rab7A is needed for their proper formation and function ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells)). This indicates Rab7A can have a *signaling facilitator* role, at least in specific cell types, linking endosomal trafficking with downstream gene activation. Additionally, Rab7A intersects with metabolic pathways; for instance, in conditions of cholesterol overload (such as in Niemann-Pick type C disease where cholesterol transport out of lysosomes is impaired), Rab7A has been shown to exacerbate or alleviate lipid accumulation depending on its activity status ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a)). Rab7A likely promotes the clearance or movement of cholesterol-laden endosomes, as Rab7A knockdown in NPC disease models led to worsened cholesterol storage ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a)). These examples illustrate that Rab7A’s influence extends beyond simple vesicle transport to broader cellular physiology, affecting signaling cascades, immune functions, and metabolic homeostasis.

## Clinical Significance and Disease Associations  
Given its central role in vesicle trafficking, it is not surprising that RAB7A has been linked to human diseases when its function is perturbed. The most direct connection is seen in a dominantly inherited peripheral neuropathy known as **Charcot–Marie–Tooth type 2B (CMT2B)**. Missense mutations in the RAB7A gene (such as V162M, L129F, and K157N among others) cause this disease ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937)). CMT2B is characterized by progressive degeneration of peripheral sensory neurons, often leading to sensory loss and ulcerations in the extremities ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Charcot%E2%80%93Marie%E2%80%93Tooth%20disease%20is%20the%20most,dynamics%20are%20further%20disrupted%20in)). At the molecular level, these disease-causing mutations typically affect Rab7A’s GTPase cycle – several CMT2B mutations result in a protein with *impaired GTP hydrolysis*, meaning Rab7A remains abnormally locked in its active state ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937)). This hyperactive Rab7A causes dysfunction in endosomal trafficking: neurons from patients (or animal models) show enlarged, stalled endolysosomal structures and defects in axonal transport of cargo ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in)). A prevailing hypothesis is that CMT2B mutants disrupt the normal endocytic trafficking of neurotrophin receptors critical for neuron survival. In support of this, studies have shown that Rab7A CMT2B mutants misregulate the retrograde transport of NGF/TrkA signaling endosomes in neurons, leading to reduced trophic support for distal axons ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body)). Furthermore, as noted above, mutant Rab7A’s inability to properly release organelle contact sites (due to stalled GTP hydrolysis) can lead to organelle dysregulation – the 2023 study by Wong *et al.* demonstrated that a CMT2B Rab7A mutation prolonged mitochondria–lysosome contacts and caused secondary mitochondrial fragmentation in peripheral neurons ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in)). These cellular defects ultimately manifest as the axonal degeneration and sensory neuropathy observed clinically. While CMT2B is rare, it underscores the importance of Rab7A’s precise regulation in neuronal health. Notably, because CMT2B mutations confer a gain-of-function (hyperactive Rab7A), therapeutic strategies are being explored to *normalize* Rab7A activity in patients – for example, drugs that could enhance Rab7A’s GTP hydrolysis or disrupt its prolonged actions are of research interest.

Rab7A has also been associated with infectious disease processes. Certain pathogens hijack or avoid Rab7A-mediated pathways to enhance their survival inside host cells. A classic example is the VacA cytotoxin of *Helicobacter pylori*, which causes host-cell vacuolation; Rab7A is required for VacA-induced vacuole formation, likely because the toxin co-opts the late endosomal compartment (where Rab7 resides) to create large vacuoles ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=important%20regulators%20of%20vesicular%20transport,provided%20by%20RefSeq%2C%20Jul%202008)). Additionally, intracellular bacteria such as *Salmonella* and *Legionella* produce effector proteins that target Rab7. *Salmonella* SopD2, for instance, can bind to endosomal membranes and is thought to interfere with Rab7 recruitment or function, thereby delaying phagolysosome formation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=and%20multifunctional%20SNARE%20regulators,Autophagy)). *Legionella pneumophila* secretes factors that prevent Rab7A from associating with their containing vacuole, allowing the pathogen to avoid lysosomal destruction ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=,Autophagy)). These interactions highlight Rab7A as a battleground during host-pathogen interactions: its normal role would be to deliver bacteria to degradative lysosomes, and pathogens that evolve ways to circumvent Rab7A can persist inside cells. Understanding these mechanisms is driving interest in Rab7A as a potential target to bolster host cell clearance of pathogens or to prevent toxin-induced damage.

Rab7A dysregulation has implications in cancer biology as well. Altered expression of RAB7A is observed in various cancers, and it can influence tumor cell behavior. In some contexts, Rab7A appears to promote oncogenic processes: for example, **gastric cancer** tissues have been found to overexpress Rab7 relative to normal tissue, and higher Rab7 levels correlated with more lymph node metastasis and poorer patient prognosis ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results)). Functionally, increasing Rab7A in gastric cancer cell lines enhanced their proliferation, invasion, and migration, partly via activating the PI3K–AKT signaling pathway ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results)). Similarly, *in vivo* and *in vitro* studies of **melanoma** have shown that Rab7A supports tumor progression. High Rab7A expression is associated with a greater risk of metastasis in melanoma patients ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L67%20and%20high,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a)), and melanoma cell lines express Rab7A at significantly higher levels than normal melanocytes ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly)). Rab7A in melanoma was recently found to interact functionally with a lysosomal cation channel (TPC2), enhancing TPC2 activity which in turn stabilizes the pro-tumorigenic factor MITF; this axis (Rab7A–TPC2–MITF) promotes melanoma cell growth and invasion ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction)). On the other hand, there are reports in certain cancer types that suppressing Rab7A can impede tumor growth: for example, silencing RAB7A in breast cancer cells reduced their proliferation and ability to form tumors in mice ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells)). These findings suggest Rab7A’s role in cancer may be context-dependent but often crucial – it can modulate signaling pathways (like AKT or β-catenin) and affect the turnover of proteins that restrain or promote cell motility and survival. Clinically, RAB7A expression is being evaluated as a prognostic biomarker in some cancers (e.g., high RAB7A portending worse outcomes in gastric and liver cancers) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells)).

The broad involvement of Rab7A in disease has motivated interest in it as a therapeutic target. One promising avenue is the development of small molecules that modulate Rab7A activity. Researchers have identified compounds that can inhibit Rab7A – for instance, CID1067700 is a selective small-molecule Rab7 inhibitor that was shown to arrest the growth of B-cell lymphomas ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of)). In experimental models, treating lymphoma cells with this Rab7 inhibitor caused dose-dependent suppression of cell proliferation and induced cell death, and it also reduced tumor growth in mice xenografts ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of)). These effects are likely due to the compound disrupting Rab7A’s function in endosomal signaling (such as NF-κB activation) and nutrient trafficking, which lymphoma cells rely on ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells)). Moreover, high RAB7A expression was observed in aggressive lymphomas and linked to poorer patient survival, supporting the idea that targeting Rab7A could be beneficial ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas)). Beyond cancer, therapeutic modulation of Rab7A is being considered in contexts like neurodegeneration and infectious disease. While no Rab7-specific drugs are in clinical use yet, these studies provide a proof-of-concept that Rab7A’s activity is druggable and that altering its function can have tangible effects on disease outcomes. It is a vivid example of how understanding a fundamental cell biology protein can open up new strategies for intervention in disease pathways.

## Recent Developments (2023–2024)  
**Neuropathy and Organelle Contacts:** A significant recent advancement in Rab7A research is the deeper understanding of how Rab7A mutations cause neuropathy via organelle contact site dysregulation. In *PNAS* (2023), Wong *et al.* investigated peripheral neurons from a CMT2B mouse model carrying a Rab7a mutation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Significance)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged)). They discovered that mutant Rab7A leads to *prolonged mitochondria–lysosome contacts* in axons, due to the mutant’s inability to hydrolyze GTP and disengage from lysosomal membranes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in)). These extended contacts were not merely a curiosity; they resulted in downstream abnormalities in mitochondrial movement and function, contributing to axonal degeneration and sensory loss in the mice ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in)). This work highlighted a new pathway of disease: beyond trafficking defects, CMT2B may be a disorder of organelle tethering, with Rab7A hyperactivity “freezing” critical organelle dynamics. It underscores how precisely balanced Rab7A activity must be for neuronal health. The study’s insights could help direct therapies that specifically aim to restore normal contact dynamics (for example, by enhancing the release of Rab7A from lysosomes).

**Rab7A in Cancer Progression:** In the cancer research arena, 2023 saw new findings about Rab7A’s role in melanoma. In *Nature Communications* (2024), Garg et al. demonstrated that Rab7a acts as an enhancer of TPC2 (Two-Pore Channel 2) activity, forming a functional unit that drives melanoma cell proliferation and metastasis ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction)). Mechanistically, Rab7a was found to physically interact with TPC2 on endolysosomal membranes and increase its calcium-release channel activity ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=In%20proteomics%20studies%20Rab7a%20was,and%20function%2C%20especially%20by%20direct)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction)). This heightened TPC2 activity led to downstream stabilization of β-catenin and the melanoma oncogene MITF, via altered degradation of GSK3β in lysosomes ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L110%20activation%20enhanced,Rab7a)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=activation%20enhanced%20by%20Rab7a%20increases,Rab7a)). Functionally, the presence of Rab7a was shown to be critical: the protumor effects of TPC2 (such as enhanced invasion and growth) were abolished if Rab7a was absent or inhibited ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly)). Notably, applying a Rab7A inhibitor reversed TPC2’s effects on melanoma cells, hinting at therapeutic potential ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L100%20effect%20of,of%20both%20proteins%20being%20particularly)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly)). This research not only elaborates a novel Rab7A-mediated signaling axis in cancer (tying together Rab7A, ion channels, and canonical growth pathways), but also reinforces that high Rab7A levels in tumors are functionally important and not just a bystander effect. Concordantly, other recent studies (2021–2023) reported that high RAB7A expression promotes tumor aggressiveness in gastric, liver, and breast cancers ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells)), making Rab7A a topic of interest for new cancer prognostic markers and targeted therapies.

**Autophagy and Aging Research:** Emerging work in 2023 has also examined Rab7A in the context of organismal aging and neurodegeneration. For example, an experimental study in *Drosophila* (2023) screened various small GTPases for their effects on neuronal autophagy and lifespan ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=autolysosome%20maturation%2C%20and%20among%20these,lifespan%2C%20and%20improves%20the%20climbing)). Intriguingly, it found that constitutively active Rab7 (a GTP-locked form) *in neurons* led to a blockage in autophagic degradation and significantly shortened the flies’ lifespan ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases)). This result aligns with the idea that Rab7A’s activity must turn off at the right time; a Rab7A that cannot turn off effectively jams the autophagy process (by perhaps over-tethering lysosomes or preventing cargo turnover). In contrast, boosting other GTPases like Rab2 or Arl8 enhanced autophagy and longevity in the same model ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases)). These findings provide a nuanced view: while Rab7A is necessary for autophagosome-lysosome fusion, too much Rab7A activity is detrimental. For neurodegenerative diseases characterized by autophagy defects, this suggests that interventions might need to *modulate* Rab7A rather than simply activate it. In fact, a balanced upregulation of lysosomal clearance (perhaps via other effectors or temporal control of Rab7A) could be more beneficial than constitutive Rab7A activation.

**Therapeutic Targeting:** On the therapeutic front, the concept of targeting Rab7A is gaining traction. A recent study in *Frontiers in Oncology* (2024) reported on a first-in-class Rab7A inhibitor, with evidence that inhibiting Rab7A can induce apoptosis in lymphoma cells and improve survival in animal models ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of)) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of)). This small molecule (CID1067700) shows that drugging the Rab7 cycle is feasible. Since Rab7A is a regulatory protein, complete inhibition in normal cells might be harmful, but cancer cells often appear more dependent on Rab7A for their heightened metabolic and signaling needs ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas)). Ongoing research is evaluating how selectively interfering with Rab7A or its effectors can be used to treat diseases such as cancer or CMT2B neuropathy, with strategies ranging from small molecules and peptides to gene therapy.

## Conclusion  
RAB7A encodes a pivotal regulator of the late endocytic pathway, functioning at the crossroads of vesicular trafficking, degradation, and autophagy. As a small GTPase, Rab7A’s ability to switch between active and inactive states allows it to control when and where vesicles move, fuse, or interact with other organelles. It ensures that cellular cargo—ranging from growth factor receptors to pathogenic bacteria to worn-out organelles—is delivered into the lysosomal degradation route at the proper time. Rab7A’s influence extends into essential cellular activities: it governs receptor down-regulation, nutrient and signaling receptor recycling, lysosome biogenesis, and autophagosome clearance. Its importance is underscored by the myriad of interactions it has with effector proteins (HOPS, retromer, motor adaptors, etc.) and by the consequences observed when Rab7A malfunctions. 

Modern research has illuminated that Rab7A is not only a trafficking protein but also a node that connects to disease pathways. Mutations in RAB7A leading to neuropathy demonstrate how sensitive neuronal health is to endolysosomal balance. Cancer studies reveal Rab7A as a facilitator of tumor progression in certain contexts, making it a potential biomarker and target for therapy. Even in infectious disease and aging, Rab7A’s activity (or lack thereof) can tip the scales in cellular outcomes. Expert reviews and recent studies consistently refer to Rab7A as a central coordinator of late endosome and lysosome function ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)), reflecting a broad consensus in the field about its critical role. 

Going forward, the challenge and opportunity lie in translating this rich understanding of Rab7A biology into medical advances. Targeted manipulation of Rab7A or its pathways could correct specific cellular defects – such as enhancing autophagic flux in neurodegeneration or restraining metastasis in cancer. Any such interventions will require finesse, given the essential nature of Rab7A in normal physiology. Nonetheless, the continued unraveling of Rab7A’s regulatory networks and its involvement in human disease holds promise for innovative treatments that restore cellular homeostasis by fine-tuning the cell’s own trafficking machinery. 

**References:** The information above was compiled from recent authoritative sources, including primary research articles and reviews from 2018–2024. Key sources include *Frontiers in Cell and Developmental Biology* (2018) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP)), *Journal of Neuroscience* (2022) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative)), *Proceedings of the National Academy of Sciences* (2023) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in)), *Nature Communications* (2024) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis)) ([www.nature.com](https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction)), and other peer-reviewed publications as cited throughout. Each citation in the text corresponds to the specific source supporting the preceding statement, with publication details and URLs provided for verification.

## Citations

1. AnnotationURLCitation(end_index=356, start_index=174, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=RAB%20family%20members%20are%20small%2C,provided%20by%20RefSeq%2C%20Jul%202008')
2. AnnotationURLCitation(end_index=817, start_index=630, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=Expression%20Ubiquitous%20expression%20in%20brain,25%20other%20tissues%20See%20more')
3. AnnotationURLCitation(end_index=1166, start_index=1042, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and')
4. AnnotationURLCitation(end_index=1351, start_index=1167, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
5. AnnotationURLCitation(end_index=1632, start_index=1463, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
6. AnnotationURLCitation(end_index=2559, start_index=2437, title='Ras-related protein Rab-7a | DrugBank', type='url_citation', url='https://go.drugbank.com/polypeptides/P51149#:~:text=Ras,transport%20%2F%20epidermal%20growth%20factor')
7. AnnotationURLCitation(end_index=2679, start_index=2560, title='Ras-related protein Rab-7a | DrugBank', type='url_citation', url='https://go.drugbank.com/polypeptides/P51149#:~:text=,transport%20%2F%20epidermal%20growth%20factor')
8. AnnotationURLCitation(end_index=3024, start_index=2900, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and')
9. AnnotationURLCitation(end_index=3451, start_index=3289, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=the%20sites%20of%20mitochondrial%20fission,review%20will%20discuss%20the%20GEF')
10. AnnotationURLCitation(end_index=3866, start_index=3703, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=retromer%20complexes%20and%20the%20dynactin,review%20will%20discuss%20the%20GEF')
11. AnnotationURLCitation(end_index=4231, start_index=4060, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy')
12. AnnotationURLCitation(end_index=4373, start_index=4232, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
13. AnnotationURLCitation(end_index=4732, start_index=4583, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by')
14. AnnotationURLCitation(end_index=5451, start_index=5291, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP')
15. AnnotationURLCitation(end_index=5769, start_index=5658, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001')
16. AnnotationURLCitation(end_index=6096, start_index=5930, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
17. AnnotationURLCitation(end_index=6513, start_index=6402, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001')
18. AnnotationURLCitation(end_index=7237, start_index=7064, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=compartments%2C%20which%20are%20linked%20maturationally,E18%20rat%20hippocampal%20neurons%20of')
19. AnnotationURLCitation(end_index=7422, start_index=7238, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
20. AnnotationURLCitation(end_index=7998, start_index=7829, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
21. AnnotationURLCitation(end_index=8165, start_index=7999, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
22. AnnotationURLCitation(end_index=8672, start_index=8521, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=flux%20of%20late%20endosomes,dependent%20dynein%2Fdynactin%20recruitment')
23. AnnotationURLCitation(end_index=9469, start_index=9285, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
24. AnnotationURLCitation(end_index=9950, start_index=9766, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
25. AnnotationURLCitation(end_index=10120, start_index=9951, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
26. AnnotationURLCitation(end_index=10443, start_index=10259, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
27. AnnotationURLCitation(end_index=10895, start_index=10751, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=leading%20to%20an%20ulcero,We%20further%20discuss%20the%20current')
28. AnnotationURLCitation(end_index=11080, start_index=10896, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
29. AnnotationURLCitation(end_index=11538, start_index=11387, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body')
30. AnnotationURLCitation(end_index=11910, start_index=11733, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=Intracellular%20endosomal%20trafficking%20controls%20the,such%20as%20coordination%20of%20recycling')
31. AnnotationURLCitation(end_index=12080, start_index=11911, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic')
32. AnnotationURLCitation(end_index=12476, start_index=12306, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
33. AnnotationURLCitation(end_index=12962, start_index=12792, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
34. AnnotationURLCitation(end_index=14048, start_index=13938, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=Drosophila%20melanogaster,Nerve')
35. AnnotationURLCitation(end_index=14203, start_index=14049, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo')
36. AnnotationURLCitation(end_index=14620, start_index=14454, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=enzymatic%20degradation%20happens,lifespan%2C%20climbing%20ability%2C%20and%20autophagy')
37. AnnotationURLCitation(end_index=14775, start_index=14621, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo')
38. AnnotationURLCitation(end_index=15387, start_index=15232, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
39. AnnotationURLCitation(end_index=15758, start_index=15592, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
40. AnnotationURLCitation(end_index=16380, start_index=16233, title='RAB7A GTPase Is Involved in Mitophagosome Formation and Autophagosome-Lysosome Fusion in N2a Cells Treated with the Prion Protein Fragment 106-126 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/36449254/#:~:text=Lysosome%20Fusion%20in%20N2a%20Cells,we%20show%20that%20RAB7A%2C%20a')
41. AnnotationURLCitation(end_index=16896, start_index=16715, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
42. AnnotationURLCitation(end_index=17087, start_index=16897, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
43. AnnotationURLCitation(end_index=17472, start_index=17291, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
44. AnnotationURLCitation(end_index=17770, start_index=17639, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,Accessory')
45. AnnotationURLCitation(end_index=18227, start_index=18067, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
46. AnnotationURLCitation(end_index=18418, start_index=18228, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
47. AnnotationURLCitation(end_index=19231, start_index=19047, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
48. AnnotationURLCitation(end_index=19802, start_index=19661, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
49. AnnotationURLCitation(end_index=20482, start_index=20341, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
50. AnnotationURLCitation(end_index=20632, start_index=20483, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by')
51. AnnotationURLCitation(end_index=21358, start_index=21220, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Armus%20also%20acts%20in%20autophagy,When%20Armus%20is')
52. AnnotationURLCitation(end_index=21526, start_index=21359, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab5%20on%20late%20endosomes%2C%20i,functions%20in%20their%20respective%20organisms')
53. AnnotationURLCitation(end_index=21911, start_index=21740, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy')
54. AnnotationURLCitation(end_index=22500, start_index=22331, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic')
55. AnnotationURLCitation(end_index=22669, start_index=22501, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=is%20particularly%20important%20in%20the,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial')
56. AnnotationURLCitation(end_index=23523, start_index=23353, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
57. AnnotationURLCitation(end_index=23885, start_index=23715, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
58. AnnotationURLCitation(end_index=24312, start_index=24139, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=switches%20direct%20activity%20at%20endosomal,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial')
59. AnnotationURLCitation(end_index=24880, start_index=24728, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
60. AnnotationURLCitation(end_index=25240, start_index=25088, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
61. AnnotationURLCitation(end_index=25865, start_index=25707, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
62. AnnotationURLCitation(end_index=26182, start_index=26024, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
63. AnnotationURLCitation(end_index=26930, start_index=26814, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937')
64. AnnotationURLCitation(end_index=27269, start_index=27079, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Charcot%E2%80%93Marie%E2%80%93Tooth%20disease%20is%20the%20most,dynamics%20are%20further%20disrupted%20in')
65. AnnotationURLCitation(end_index=27619, start_index=27503, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937')
66. AnnotationURLCitation(end_index=27979, start_index=27819, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
67. AnnotationURLCitation(end_index=28170, start_index=27980, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
68. AnnotationURLCitation(end_index=28663, start_index=28512, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body')
69. AnnotationURLCitation(end_index=29206, start_index=29018, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics')
70. AnnotationURLCitation(end_index=29397, start_index=29207, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
71. AnnotationURLCitation(end_index=30530, start_index=30336, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=important%20regulators%20of%20vesicular%20transport,provided%20by%20RefSeq%2C%20Jul%202008')
72. AnnotationURLCitation(end_index=30957, start_index=30821, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=and%20multifunctional%20SNARE%20regulators,Autophagy')
73. AnnotationURLCitation(end_index=31215, start_index=31121, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=,Autophagy')
74. AnnotationURLCitation(end_index=32135, start_index=32044, title='Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results')
75. AnnotationURLCitation(end_index=32396, start_index=32305, title='Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results')
76. AnnotationURLCitation(end_index=32750, start_index=32599, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L67%20and%20high,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
77. AnnotationURLCitation(end_index=32909, start_index=32751, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
78. AnnotationURLCitation(end_index=33162, start_index=33004, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
79. AnnotationURLCitation(end_index=33317, start_index=33163, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
80. AnnotationURLCitation(end_index=33745, start_index=33574, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
81. AnnotationURLCitation(end_index=33908, start_index=33746, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
82. AnnotationURLCitation(end_index=34259, start_index=34134, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
83. AnnotationURLCitation(end_index=34789, start_index=34664, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
84. AnnotationURLCitation(end_index=35319, start_index=35166, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
85. AnnotationURLCitation(end_index=35679, start_index=35526, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
86. AnnotationURLCitation(end_index=35797, start_index=35680, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of')
87. AnnotationURLCitation(end_index=36129, start_index=35977, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
88. AnnotationURLCitation(end_index=36407, start_index=36300, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas')
89. AnnotationURLCitation(end_index=37336, start_index=37239, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Significance')
90. AnnotationURLCitation(end_index=37497, start_index=37337, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
91. AnnotationURLCitation(end_index=37841, start_index=37681, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
92. AnnotationURLCitation(end_index=38023, start_index=37842, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
93. AnnotationURLCitation(end_index=38413, start_index=38225, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics')
94. AnnotationURLCitation(end_index=38604, start_index=38414, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
95. AnnotationURLCitation(end_index=39548, start_index=39377, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
96. AnnotationURLCitation(end_index=39711, start_index=39549, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
97. AnnotationURLCitation(end_index=40019, start_index=39856, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=In%20proteomics%20studies%20Rab7a%20was,and%20function%2C%20especially%20by%20direct')
98. AnnotationURLCitation(end_index=40182, start_index=40020, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
99. AnnotationURLCitation(end_index=40463, start_index=40337, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L110%20activation%20enhanced,Rab7a')
100. AnnotationURLCitation(end_index=40595, start_index=40464, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=activation%20enhanced%20by%20Rab7a%20increases,Rab7a')
101. AnnotationURLCitation(end_index=40946, start_index=40775, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
102. AnnotationURLCitation(end_index=41101, start_index=40947, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
103. AnnotationURLCitation(end_index=41369, start_index=41215, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L100%20effect%20of,of%20both%20proteins%20being%20particularly')
104. AnnotationURLCitation(end_index=41524, start_index=41370, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
105. AnnotationURLCitation(end_index=42066, start_index=41941, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
106. AnnotationURLCitation(end_index=42615, start_index=42440, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=autolysosome%20maturation%2C%20and%20among%20these,lifespan%2C%20and%20improves%20the%20climbing')
107. AnnotationURLCitation(end_index=42952, start_index=42797, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
108. AnnotationURLCitation(end_index=43438, start_index=43283, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
109. AnnotationURLCitation(end_index=44385, start_index=44232, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
110. AnnotationURLCitation(end_index=44503, start_index=44386, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of')
111. AnnotationURLCitation(end_index=44889, start_index=44782, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas')
112. AnnotationURLCitation(end_index=46814, start_index=46645, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
113. AnnotationURLCitation(end_index=46999, start_index=46815, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
114. AnnotationURLCitation(end_index=48100, start_index=47940, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP')
115. AnnotationURLCitation(end_index=48304, start_index=48135, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
116. AnnotationURLCitation(end_index=48523, start_index=48363, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
117. AnnotationURLCitation(end_index=48705, start_index=48524, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
118. AnnotationURLCitation(end_index=48922, start_index=48738, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
119. AnnotationURLCitation(end_index=49085, start_index=48923, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')